Area of Research: Combination Therapy

2020 Grant Recipients

• Nidhi Sahni, PhD, MD Anderson Cancer Center
  Liz Tilberis Early Career Award
  Systems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
• James Duncan, PhD, Fox Chase Cancer Center
  Liz Tilberis Early Career Award
  Exploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer

2019 Grant Recipients

• Shariska Petersen, MD, University of Kansas Medical Center Research Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Cyclin E and BRD4 as Markers for a New PARPi Drug Combination
• Shuai Wu, PhD, The Wistar Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Synthetic Lethality for ARID1A Mutation in Ovarian Cancer

2018 Grant Recipients

• Gordon Mills, MD, PhD, MD Anderson Cancer Center
  Collaborative Research Development Grant
  Rational Combination Therapy in Ovarian Cancer

2017 Grant Recipients

• Ronald Chandler, PhD, Michigan State University
  Liz Tilberis Early Career Award
  Integrated Roles of Epigenetics and Cell Signaling in Ovarian Cancer

2015 Grant Recipients

• Bob McGray, PhD, Roswell Park Cancer Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Combination Oncolytic Virotherapy/ACT for Ovarian Cancer Treatment
• Sarah Adams, MD, University of New Mexico
  Liz Tilberis Early Career Award
  A Combination Therapy for Hereditary Ovarian Cancer
• Kris Wood, PhD, Duke University
  Liz Tilberis Early Career Award
  Defining New Combination Therapies for High-grade Serous Ovarian Cancer

2014 Grant Recipients

• Ursula Matulonis, MD, Dana Farber Cancer Institute
  Collaborative Research Development Grant
  Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy

2012 Grant Recipients

• See-Hyoung Park, PhD, Stanford University
  Ann and Sol Schreiber Mentored Investigator Award
  Targeting Ovarian Cancer with Combination of Olaparib and Bepridil

2011 Grant Recipients

• Sarah Adams, MD, University of Pennsylvania
  Liz Tilberis Early Career Award
  Development of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer

2005 Grant Recipients

• Andrew Li, MD, Cedars-Sinai Medical Center
  Liz Tilberis Early Career Award
  Testing Medications for Other Conditions to Treat Ovarian Cancer

2003 Grant Recipients

• Parameshwar Mahareshti, DVM, University of Alabama - Birmingham
  Individual Investigator Award
  A New Combination Drug Treatment for Ovarian Cancer

2000 Grant Recipients

• Wei Hu, MD, PhD, MD Anderson Cancer Center
  Individual Investigator Award
  Effects of a Novel Combination Drug Treatment on Cell Lines Derived from Human Ovarian Cancer